Your session is about to expire
← Back to Search
30 minute, dual site stimulation for Type 2 Diabetes (U/S_in_T2DM Trial)
U/S_in_T2DM Trial Summary
This trialwill explore if ultrasound can help manage diabetes symptoms in people with type 2 diabetes.
U/S_in_T2DM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowU/S_in_T2DM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.U/S_in_T2DM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking diabetes medication like Metformin or similar.I am not pregnant or breastfeeding and have a negative pregnancy test.Your body mass index (BMI) falls between 18 and 40.0.I have not had major surgery in the last 3 months.I have been diagnosed with type 2 diabetes for at least 3 months.I have had or will have an abdominal ultrasound within a month before or during the study.I have serious health issues due to long-term or uncontrolled diabetes.I currently have an active cancer.I have not lost or donated more than 500 mL of blood in the last 2 months.I have had severe low blood sugar episodes often.I haven't had any heart surgery in the last 6 months.I have had surgery for obesity or other stomach/intestine surgeries.I or my family have a history of blood clots.My current diabetes treatment needs to be stronger.I have type 1 or type 2 diabetes and am on insulin or specific diabetes medications.I have liver disease or abnormal liver tests.I understand the study and can communicate my health needs.I have a history of kidney problems or abnormal kidney tests.I have or had heart rhythm problems or heart disease.I am currently taking medication that affects my blood sugar or insulin levels.I currently do not have any active infections, including COVID-19.I am between 21 and 75 years old.My screening shows a risk of very low blood sugar or poorly controlled diabetes.My thyroid hormone levels have been stable for the last 3 months.
- Group 1: 30 minute, dual site stimulation
- Group 2: 60 minute, dual site stimulation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have been recruited for this experiment?
"Affirmative. According to the information hosted on clinicaltrials.gov, recruitment for this medical trial is still underway since its original posting date of November 1st 2022 and subsequent update dated November 10th 2022. This study requires 30 participants from one site in particular."
What requirements must be met in order to become part of this experiment?
"This clinical trial requires candidates to be between 21 and 75 years of age, as well as have type 2 diabetes mellitus. Altogether, 30 participants are needed for the study."
Is this clinical experiment open to individuals below the age of seventy?
"As outlined in the trial's eligibility specifications, patients must be between 21 and 75 years of age to partake."
Is this clinical experiment currently enlisting participants?
"According to the data featured on clinicaltrials.gov, this medical trial is actively seeking volunteers for enrollment. The study was initially presented on November 1st 2022 and has been recently modified as of November 10th 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger